ME
NU
Donate

Fighting Parkinson’s

Development of a cutting-edge therapy to replace the dopamine neurons that degenerate in Parkinson’s disease

Harvard University
Cambridge, MA Dr. Penny Hallett

The National Stem Cell Foundation (NSCF) and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are partnering to fund the development of a cutting-edge therapy to replace the dopamine neurons that degenerate in Parkinson’s disease, the second most common brain disease after Alzheimer’s.

The partnership supports the pre-clinical work of Ole Isacson, MD, director of the Neuroregeneration Research Institute at McLean Hospital and principal faculty at Harvard Stem Cell Institute, exploring implantation of dopamine neurons created from engineered stem cells. The treatment aims to alleviate or prevent Parkinson’s motor symptoms of tremor, rigidity and slowness.